Nothing Special   »   [go: up one dir, main page]

ITMI20021078A1 - USE OF TOPICAL TRANSDERMAL SYSTEMS FOR THE PREVENTION AND TREATMENT OF PRIMARY DYSMENORRHEA - Google Patents

USE OF TOPICAL TRANSDERMAL SYSTEMS FOR THE PREVENTION AND TREATMENT OF PRIMARY DYSMENORRHEA

Info

Publication number
ITMI20021078A1
ITMI20021078A1 IT2002MI001078A ITMI20021078A ITMI20021078A1 IT MI20021078 A1 ITMI20021078 A1 IT MI20021078A1 IT 2002MI001078 A IT2002MI001078 A IT 2002MI001078A IT MI20021078 A ITMI20021078 A IT MI20021078A IT MI20021078 A1 ITMI20021078 A1 IT MI20021078A1
Authority
IT
Italy
Prior art keywords
prevention
treatment
transdermal systems
primary dysmenorrhea
topical transdermal
Prior art date
Application number
IT2002MI001078A
Other languages
Italian (it)
Inventor
Stefano Camponovo
Original Assignee
Technipharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technipharma Llc filed Critical Technipharma Llc
Priority to IT2002MI001078A priority Critical patent/ITMI20021078A1/en
Publication of ITMI20021078A0 publication Critical patent/ITMI20021078A0/en
Priority to AU2003230136A priority patent/AU2003230136A1/en
Priority to PCT/IB2003/002048 priority patent/WO2003097021A2/en
Publication of ITMI20021078A1 publication Critical patent/ITMI20021078A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2002MI001078A 2002-05-21 2002-05-21 USE OF TOPICAL TRANSDERMAL SYSTEMS FOR THE PREVENTION AND TREATMENT OF PRIMARY DYSMENORRHEA ITMI20021078A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2002MI001078A ITMI20021078A1 (en) 2002-05-21 2002-05-21 USE OF TOPICAL TRANSDERMAL SYSTEMS FOR THE PREVENTION AND TREATMENT OF PRIMARY DYSMENORRHEA
AU2003230136A AU2003230136A1 (en) 2002-05-21 2003-05-15 Use of transdermal topical systems for the prevention and treatment of primary dysmenorrhea
PCT/IB2003/002048 WO2003097021A2 (en) 2002-05-21 2003-05-15 Use of transdermal topical systems for the prevention and treatment of primary dysmenorrhea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI001078A ITMI20021078A1 (en) 2002-05-21 2002-05-21 USE OF TOPICAL TRANSDERMAL SYSTEMS FOR THE PREVENTION AND TREATMENT OF PRIMARY DYSMENORRHEA

Publications (2)

Publication Number Publication Date
ITMI20021078A0 ITMI20021078A0 (en) 2002-05-21
ITMI20021078A1 true ITMI20021078A1 (en) 2003-11-21

Family

ID=11449935

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI001078A ITMI20021078A1 (en) 2002-05-21 2002-05-21 USE OF TOPICAL TRANSDERMAL SYSTEMS FOR THE PREVENTION AND TREATMENT OF PRIMARY DYSMENORRHEA

Country Status (3)

Country Link
AU (1) AU2003230136A1 (en)
IT (1) ITMI20021078A1 (en)
WO (1) WO2003097021A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100113075A (en) * 2008-05-21 2010-10-20 테이코쿠 팔마 유에스에이, 인코포레이티드 Treatment of dysmenorrhea via transdermal administration of nonsteroidal anti-inflammatory drugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
DE10032537A1 (en) * 2000-07-05 2002-01-31 Labtec Gmbh Dermal system containing 2- (3-benzophenyl) propionic acid
DE10049225A1 (en) * 2000-09-28 2002-04-11 Labtec Gmbh Dermal therapeutic system comprises diclofenac sodium in an acrylate copolymer matrix on a polyester web

Also Published As

Publication number Publication date
AU2003230136A1 (en) 2003-12-02
WO2003097021A3 (en) 2004-01-29
ITMI20021078A0 (en) 2002-05-21
WO2003097021A2 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
NO20026010D0 (en) Substituted quinazoline derivatives and their use as inhibitors
IS6934A (en) New spirotycyclic derivatives and their use as phosphodiesterase-7 inhibitors
DK1578755T3 (en) Phosphonooxyguinalin derivatives and their pharmaceutical use
DK1133477T3 (en) Substituted benzimidazoles and their use as pair inhibitors
DK1564210T5 (en) 4-Oxoquinoline Compounds and Their Use as HIV Integrase Inhibitors
NO20014409D0 (en) Dimeric compounds and their use as inhibitors of neuraminidase
NO20052462D0 (en) Combination therapy using 1-amino cyclohexane derivatives and acetylcholinesterase inhibitors
AT9258U3 (en) TRANSDERMAL PLASTER FOR THE ADMINISTRATION OF FENTANYL
DE60317296D1 (en) Security processor mirroring
DK1478629T3 (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterial agents
EE200100373A (en) Benzoheterocycles and their use as MEK inhibitors
DK1565136T3 (en) Compositions for Transdermal Oxybutynin Therapy
NO20035366D0 (en) Benzoylsulfonamides and sulfonylbenzamidines for use as antitumor agents
NO20025357L (en) Anthranylamides and their use as drugs
DE60319951D1 (en) AMINOCYCLIC SUBSTITUTED PYRROLOPYRIMIDIN DERIVATIVES AND PYRROLOPYRIDINE DERIVATIVES
DE60306627D1 (en) DYNAMIC SAFETY SYSTEM
EE05056B1 (en) Use of IL-18 inhibitors in the manufacture of a medicament for the treatment and / or prevention of atherosclerosis
DK1387838T3 (en) Cyanoanthranylamide derivatives and their use as drugs
DE60218977D1 (en) Face protection device
EE05534B1 (en) Use of IL-18 inhibitors in the manufacture of a medicament for the treatment and / or prevention of cardiomyopathy
ATE457168T1 (en) TRANSDERMAL THERAPEUTIC SYSTEM OF GESTODE
NO20050689L (en) Therapeutic use
AU2003249930A1 (en) Proteaseome inhibitors for the treatment of herpesviridae infected individuals
ITMI20021078A0 (en) USE OF TOPICAL TRANSDERMAL SYSTEMS FOR THE PREVENTION AND TREATMENT OF PRIMARY DYSMENORRHEA
EE200300582A (en) Use of IL-18 inhibitors to treat or prevent central nervous system damage